Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MAXLINEAR, INCMXL · Entity 3882 | VP, Product Line Marketing | February 20, 2023 | February 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MAXLINEAR, INC
Report date February 20, 2023 · Filed February 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 189,534 |
Reported balance
After 2023-02-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-20 · Exercise / conversion · Acquired 523 · Balance 189,534 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 189,011 |
Reported balance
After 2023-02-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-02-20 · Tax withholding · Disposed 523 · Balance 189,011 F2: On February 20, 2023, the Reporting Person's RSUs vested. The RSUs were settled on February 21, 2023, the first business day following the vesting date. The closing price of the Issuer's Common Stock on February 17, 2023 was the settlement price used to calculate the shares withheld. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,165 |
Reported balance
After 2023-02-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-20 · Exercise / conversion · Disposed 523 · Balance 3,165 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the 4,221 RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
F2: On February 20, 2023, the Reporting Person's RSUs vested. The RSUs were settled on February 21, 2023, the first business day following the vesting date. The closing price of the Issuer's Common Stock on February 17, 2023 was the settlement price used to calculate the shares withheld.
F3: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the 4,221 RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2023 Filed Feb 21, 2023 18:57 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 523 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000071 · wf-form4_167702382923369.xml · derivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,165 Underlying: Common Stock · 523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the 4,221 RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026. F3 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the 4,221 RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026. Read SEC document |
| February 20, 2023 Filed Feb 21, 2023 18:57 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 523 | $36.74 | $19,215.02 |
DisclosureSEC source: 0001288469-23-000071 · wf-form4_167702382923369.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,011 F2 · price: On February 20, 2023, the Reporting Person's RSUs vested. The RSUs were settled on February 21, 2023, the first business day following the vesting date. The closing price of the Issuer's Common Stock on February 17, 2023 was the settlement price used to calculate the shares withheld. Read SEC document |
| February 20, 2023 Filed Feb 21, 2023 18:57 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionCommon Stock | 523 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000071 · wf-form4_167702382923369.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 271 | $38.87 | $10,533.77 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 14 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,478 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 505 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 13 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,749 F5 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 407 | $38.87 | $15,820.09 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 12 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,244 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 11 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,651 F5 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 1,368 | $38.87 | $53,174.16 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 10 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,894 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 2,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 9 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,262 F4 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 2,053 | $38.87 | $79,800.11 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 8 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,720 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 3,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 7 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,773 F4 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 8,305 | $38.87 | $322,815.35 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 6 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,960 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 15,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 5 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,265 F3 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 12,458 | $38.87 | $484,242.46 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 4 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,842 Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 23,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,300 F3 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 3,274 | $38.87 | $127,260.38 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,164 F2 · shares: On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:48 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 5,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000055 · wf-form4_167582446468420.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,438 F1 · shares: Represents shares of Common Stock issued to the Reporting Person for the 2022 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 3, 2023. Read SEC document |
| January 03, 2023 Filed Feb 3, 2023 20:10 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantRestricted Stock Units · Derivative | 9,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-23-000033 · wf-form4_167547303241028.xml · derivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,951 Underlying: Common Stock · 9,951 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the RSUs subject to the award will vest on February 20, 2024, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2027. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the RSUs subject to the award will vest on February 20, 2024, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2027. Read SEC document |
| August 20, 2022 Filed Aug 22, 2022 18:11 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000163 · wf-form4_166120629375426.xml · derivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,457 Underlying: Common Stock · 772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 7,794 RSUs subject to the award will vest on August 20, 2021; twenty percent (20%) of the RSUs subject to the award will vest on August 20, 2022; thirty percent (30%) of the RSUs subject to the award will vest on August 20, 2023; and forty percent (40%) of the RSUs subject to the award will vest on August 20, 2024, such that all the RSUs subject to the award will then be fully vested. F3 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 7,794 RSUs subject to the award will vest on August 20, 2021; twenty percent (20%) of the RSUs subject to the award will vest on August 20, 2022; thirty percent (30%) of the RSUs subject to the award will vest on August 20, 2023; and forty percent (40%) of the RSUs subject to the award will vest on August 20, 2024, such that all the RSUs subject to the award will then be fully vested. Read SEC document |
| August 20, 2022 Filed Aug 22, 2022 18:11 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 772 | $39.46 | $30,463.12 |
DisclosureSEC source: 0001288469-22-000163 · wf-form4_166120629375426.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,744 F2 · price: On August 20, 2022, the Reporting Person's RSUs vested. The RSUs were settled on August 22, 2022, the first business day following the vesting date. The closing price of the Issuer's Common Stock on August 19, 2022 was the settlement price used to calculate the shares withheld. Read SEC document |
| August 20, 2022 Filed Aug 22, 2022 18:11 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionCommon Stock | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000163 · wf-form4_166120629375426.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 449 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · derivative · entry 7 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,171 Underlying: Common Stock · 449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F6 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 9,078 RSUs subject to the award will vest on May 20, 2022; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2023; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2024; and forty percent (40%) of the RSUs subject to the award will vest on May 20, 2025, such that all the RSUs subject to the award will then be fully vested. F6 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 9,078 RSUs subject to the award will vest on May 20, 2022; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2023; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2024; and forty percent (40%) of the RSUs subject to the award will vest on May 20, 2025, such that all the RSUs subject to the award will then be fully vested. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 2,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · derivative · entry 6 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,995 Underlying: Common Stock · 2,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F5 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 25,706 RSUs subject to the award will vest on May 20, 2021; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2022; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2023; and forty percent (40%) of the RSUs subject to the award will vest on May 20, 2024, such that all the RSUs subject to the award will then be fully vested. F5 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 25,706 RSUs subject to the award will vest on May 20, 2021; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2022; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2023; and forty percent (40%) of the RSUs subject to the award will vest on May 20, 2024, such that all the RSUs subject to the award will then be fully vested. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 3,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · derivative · entry 5 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,005 Underlying: Common Stock · 3,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F4 · derivative.exercise_date: Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 22,512 RSUs subject to the award will vest on May 20, 2020; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2021; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2022; forty percent (40%) of the RSUs subject to the award will vest on May 20, 2023, such that the award shall be fully vested on May 20, 2023. F4 · derivative.expiration_date: Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 22,512 RSUs subject to the award will vest on May 20, 2020; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2021; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2022; forty percent (40%) of the RSUs subject to the award will vest on May 20, 2023, such that the award shall be fully vested on May 20, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 3,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · derivative · entry 4 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,105 Underlying: Common Stock · 3,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 20,261 RSUs subject to the award will vest on May 20, 2020; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2021; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2022; forty percent (40%) of the RSUs subject to the award will vest on May 20, 2023, such that the award will be fully vested on May 20, 2023. F3 · derivative.expiration_date: Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, ten percent (10%) of the 20,261 RSUs subject to the award will vest on May 20, 2020; twenty percent (20%) of the RSUs subject to the award will vest on May 20, 2021; thirty percent (30%) of the RSUs subject to the award will vest on May 20, 2022; forty percent (40%) of the RSUs subject to the award will vest on May 20, 2023, such that the award will be fully vested on May 20, 2023. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · derivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award will vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award will vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award will vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award will vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 10,109 | $38.45 | $388,691.05 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,958 Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:13 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionCommon Stock | 10,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000118 · wf-form4_165344122079309.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Read SEC document |
| February 20, 2022 Filed Feb 23, 2022 16:06 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000062 · wf-form4_164565038665841.xml · derivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,516 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award shall vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. F3 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award shall vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. Read SEC document |
| February 20, 2022 Filed Feb 23, 2022 16:06 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 751 | $60.83 | $45,683.33 |
DisclosureSEC source: 0001288469-22-000062 · wf-form4_164565038665841.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,671 F2 · price: On February 20, 2022, the Reporting Person's RSUs vested. The RSUs were settled on February 22, 2022, the first business day following the vesting date. The closing price of the Issuer's Common Stock on February 18, 2022 was the settlement price used to calculate the shares withheld. Read SEC document |
| February 20, 2022 Filed Feb 23, 2022 16:06 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionCommon Stock | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000062 · wf-form4_164565038665841.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 586 | $60.38 | $35,382.68 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 14 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,907 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 1,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 13 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,493 F5 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 880 | $60.38 | $53,134.40 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 12 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,404 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 1,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 11 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,284 F5 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 3,878 | $60.38 | $234,153.64 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 10 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,650 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 7,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 9 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,528 F4 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 5,814 | $60.38 | $351,049.32 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 8 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,331 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 10,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 7 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,145 F4 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 2,177 | $60.38 | $131,447.26 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 6 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,348 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 4,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 5 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,525 F3 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 3,266 | $60.38 | $197,201.08 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 4 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,473 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 6,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,739 F3 · shares: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 2,110 | $60.38 | $127,401.80 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,662 F2 · shares: On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 17:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantCommon Stock | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000049 · wf-form4_164435979990908.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,772 F1 · shares: Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:37 UTC | MAXLINEAR, INC MXL · Entity 3882 | GrantRestricted Stock Units · Derivative | 4,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-22-000022 · wf-form4_164143303519137.xml · derivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,221 Underlying: Common Stock · 4,221 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the RSUs subject to the award will vest on February 20, 2023, and twenty five percent (25%) of the RSUs subject to the award will vest annually on each February 20 thereafter, such that the award will be fully vested on February 20, 2026. Read SEC document |
| November 20, 2021 Filed Nov 23, 2021 17:08 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-21-000264 · wf-form4_163770527907318.xml · derivative · entry 3 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,031 Underlying: Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award shall vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. F3 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the 24,245 RSUs subject to the award shall vest on August 20, 2018, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on May 20, 2022. Read SEC document |
| November 20, 2021 Filed Nov 23, 2021 17:08 UTC | MAXLINEAR, INC MXL · Entity 3882 | Tax withholdingCommon Stock | 751 | $70.68 | $53,080.68 |
DisclosureSEC source: 0001288469-21-000264 · wf-form4_163770527907318.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,076 F2 · price: On November 20, 2021, the Reporting Person's RSUs vested. The RSUs were settled on November 22, 2021, the first business day following the vesting date. The closing price of the issuer's common stock on November 19, 2021 was the settlement price used to calculate the shares withheld. Read SEC document |
| November 20, 2021 Filed Nov 23, 2021 17:08 UTC | MAXLINEAR, INC MXL · Entity 3882 | Exercise / conversionCommon Stock | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001288469-21-000264 · wf-form4_163770527907318.xml · nonDerivative · entry 1 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 16:12 UTC | MAXLINEAR, INC MXL · Entity 3882 | SaleCommon Stock | 5,310 | $54.10 | $287,271.00 |
DisclosureSEC source: 0001288469-21-000230 · wf-form4_163156393318141.xml · nonDerivative · entry 2 WALSH BRENDAN · CIK 0001478342 · VP, Product Line Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,312 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.